Doximity Cash Flow from Investing Activities 2020-2025 | DOCS

Doximity annual/quarterly cash flow from investing activities history and growth rate from 2020 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Doximity cash flow from investing activities for the quarter ending March 31, 2025 was $-0.029B, a 193.95% decline year-over-year.
  • Doximity cash flow from investing activities for the twelve months ending March 31, 2025 was $0.050B, a 84.55% decline year-over-year.
  • Doximity annual cash flow from investing activities for 2025 was $-0.029B, a 193.95% decline from 2024.
  • Doximity annual cash flow from investing activities for 2024 was $0.031B, a 152.04% decline from 2023.
  • Doximity annual cash flow from investing activities for 2023 was $-0.06B, a 90.65% decline from 2022.
Doximity Annual Cash Flow Investing
(Millions of US $)
2025 $-29
2024 $31
2023 $-60
2022 $-641
2021 $-70
2020 $-13
2019 $-9
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.890B $0.570B
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.804B 58.27
Tempus AI (TEM) United States $11.365B 0.00
Hims & Hers Health (HIMS) United States $9.396B 97.63
IRhythm Technologies (IRTC) United States $4.819B 0.00
Inspire Medical Systems (INSP) United States $3.834B 59.90
Hinge Health (HNGE) United States $3.409B 0.00
Privia Health (PRVA) United States $2.635B 180.08
Enovis (ENOV) United States $1.711B 9.54
Phreesia (PHR) United States $1.608B 0.00
Schrodinger (SDGR) United States $1.493B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.334B 61.98
Omnicell (OMCL) United States $1.329B 23.45
10x Genomics (TXG) United States $1.329B 0.00
Evolent Health (EVH) United States $1.233B 105.00
Claritev (CTEV) United States $0.682B 0.00
Fulgent Genetics (FLGT) United States $0.588B 0.00
Butterfly Network (BFLY) United States $0.507B 0.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Talkspace (TALK) United States $0.462B 138.00
TruBridge (TBRG) United States $0.337B 748.33
Outset Medical (OM) United States $0.308B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.158B 0.00
EUDA Health Holdings (EUDA) Singapore $0.133B 0.00
CareCloud (CCLD) United States $0.105B 4.02
American Well (AMWL) United States $0.105B 0.00
Pulmonx (LUNG) United States $0.103B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
111 (YI) China $0.066B 0.00
HeartBeam (BEAT) United States $0.050B 0.00
P3 Health Partners (PIII) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00